Improved outcomes of renal transplantation from cardiac death donors: A 30-year single center experience

American Journal of Transplantation

Volumn 7, Issue 3, 2007, Pages 609-617

  Tojimbara, T ^a   Fuchinoue, S ^a   Iwadoh, K ^a   Koyama, I ^a   Sannomiya, A ^a   Kato, Y ^a   Nanmoku, K ^a   Kai, K ^a   Nakajima, I ^a   Toma, H ^a   Teraoka, S ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Donation after cardiac death; Kidney transplantation; Long term outcomes

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; HEPARIN; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MIZORIBINE; OKT 3; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DELAYED GRAFT FUNCTION; DRUG DOSE REDUCTION; FEMALE; GRAFT PRESERVATION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DEATH; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 33847728726     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01664.x     Document Type: Article

References (25)

1. Marchioro TL. The role of cadaveric donors in homotransplantations. In: Starzl TE, ed. Experience in renal transplantation. Philadelphia: Saunders; 1964: 54-62.
2. D'Alessandro AM, Hoffmann RM, Knechtle SJ et al. Controlled non-heart-beating donors: A potential source of extrarenal organs. Transplant Proc 1995; 27: 707-709.
3. Casavilla A, Ramirez C, Shapiro R et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 1995; 59: 197-203.
4. Cho YW, Terasaki PI, Cecka JM, Gjertson DW. Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med 1998; 338: 221-225.
5. Yokoyama I, Uchida K, Tominaga Y, Asano H, Orihara A, Takagi H. Ten-year experience in the use of double balloon catheter for kidney procurement from non-heart beating donors in cadaveric kidney transplantation. Clin Transplant 1993; 7: 258-262.
6. Ota K. Present status of kidney donation in Japan. Transplant Proc 1991; 23: 2512-2513.
7. Garcia-Rinaldi R, Lefrak EA, DeFore WW et al. In situ preservation of cadaver kidneys for transplantation: Laboratory observations and clinical application. Ann Surg 1975; 182: 576-584.
8. Kootstra G. The asystolic, or non-heartbeating, donor. Transplantation 1997; 63: 917-921.
9. Kootstra G. Statement on non-heart-beating donor programs. Transplant Proc 1995; 27: 2965.
10. Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM. Expanded criteria donors for kidney transplantation. Am J Transplant 2003; 3 (4 Suppl): 114-125.
11. Hariharan S, Johnson CP, Bresnahan BA, Tarant SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612.
12. Schweitzer RT, Sutphin BA, Bartus SA. In-situ cadaver kidney perfusion. Transplantation 1981; 32: 482-484.
13. Canafax DM, Torres A, Fryd DS et al. The effect of delayed graft function on recipients of cadaveric renal allografts. Transplantation 1986; 41: 177-181.
14. Ploeg RJ, Bockel van JH, Langendijik PTH et al. Effect of preservation solution on results of cadaveric kidney transplantation. Lancet 1992; 340: 129-136.
15. Troppmann C, Gillingham KJ, Benedetti E et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. Transplantation 1995; 59: 962-968.
16. Wijinen RMH, Booster MH, Stubenitsky BM, de Boer J, Heineman E, Kootstra G. Outcome of transplantation of non-heartbeating donor kidneys. Lancet 1995; 345: 1067-1070.
17. Andrews PA, Denton MD, Compton F, Koffman CG. Outcome of transplantation of non-heart-beating donor kidneys. Lancet 1995; 346: 53.
18. Kasiske BL, Gaston RS, Gourishankar S et al. Long-term deterioration of kidney allograft function. Am J Transplant 2005; 5: 1405-1414.
19. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383.
20. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004; 4: 1289-1295.
21. Lawen JG, Davies EA, Mourad G et al. Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric antiinterleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation. Transplantation 2003; 75: 37-43.
22. Carpenter CB. Improving the success of organ transplantation. N Engl J Med 2000; 342: 647-648.
23. Goldfarb-Rumyantzev A, Hurdle JF, Scandling J et al. Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant 2005; 20: 167-175.
24. Morris PJ. Factors influencing outcome in cadaveric renal transplantation. Br J Surg 1994; 81: 635-636.
25. Kaplan B. Overcoming barriers to long-term graft survival. Am J Kid Dis 2006; 47: S52-S64.